These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11824889)

  • 1. Radiation recall dermatitis in a patient treated with dacarbazine.
    Kennedy RD; McAleer JJ
    Clin Oncol (R Coll Radiol); 2001; 13(6):470-2. PubMed ID: 11824889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiation recall dermatitis after oral cyclophosphamide].
    Mievis C; Jansen N; Schleich F; Gennigens C; Rorive A; Jérusalem G; Fillet G; Sautois B
    Rev Med Liege; 2009 Apr; 64(4):179-81. PubMed ID: 19514535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of glucocorticoids in the treatment of fulminant hepatitis induced by dacarbazine.
    Herishanu Y; Lishner M; Kitay-Cohen Y
    Anticancer Drugs; 2002 Feb; 13(2):177-9. PubMed ID: 11901312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma.
    Treudler R; Georgieva J; Geilen CC; Orfanos CE
    J Am Acad Dermatol; 2004 May; 50(5):783-5. PubMed ID: 15097966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic cystitis in a patient receiving conventional doses of dacarbazine for metastatic malignant melanoma: case report and review of the literature.
    Mohammadianpanah M; Shirazi M; Mosalaei A; Omidvari S; Ahmadloo N
    Clin Ther; 2007 Jun; 29(6):1161-5. PubMed ID: 17692730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phototoxicity of dacarbazine (Deticene) not reinduced by temozolomide (Temodal)].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 1):500. PubMed ID: 16760848
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and side effects of dacarbazine in comparison with temozolomide in the treatment of malignant melanoma: a meta-analysis consisting of 1314 patients.
    Teimouri F; Nikfar S; Abdollahi M
    Melanoma Res; 2013 Oct; 23(5):381-9. PubMed ID: 23880781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ambiguous phenomenon of radiation and drugs: recall reactions.
    Caloglu M; Yurut-Caloglu V; Cosar-Alas R; Saynak M; Karagol H; Uzal C
    Onkologie; 2007 Apr; 30(4):209-14. PubMed ID: 17396045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
    Robert C; Dummer R; Gutzmer R; Lorigan P; Kim KB; Nyakas M; Arance A; Liszkay G; Schadendorf D; Cantarini M; Spencer S; Middleton MR
    Lancet Oncol; 2013 Jul; 14(8):733-40. PubMed ID: 23735514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation recall dermatitis from high-dose interferon alfa-2b.
    Thomas R; Stea B
    J Clin Oncol; 2002 Jan; 20(1):355-7. PubMed ID: 11773198
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation recall after a transarterial hepatic chemoembolization.
    Wunderle KA; Sands MJ
    J Vasc Interv Radiol; 2014 Jul; 25(7):1027-8. PubMed ID: 24968725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor.
    Horii M; Kobayashi T; Maeda S; Takehara K; Matsushita T
    J Dermatol; 2019 Nov; 46(11):e434-e436. PubMed ID: 31342541
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation recall dermatitis, panniculitis, and myositis following cyclophosphamide therapy: histopathologic findings of a patient affected by multiple myeloma.
    Borroni G; Vassallo C; Brazzelli V; Martinoli S; Ardigò M; Alessandrino PE; Borroni RG; Franchini P
    Am J Dermatopathol; 2004 Jun; 26(3):213-6. PubMed ID: 15166509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypopigmentation in the sites of regressed melanoma metastases after successful dacarbazine therapy.
    Roider E; Schneider J; Flaig MJ; Ruzicka T; Kunte C; Berking C
    Int J Dermatol; 2012 Sep; 51(9):1142-4. PubMed ID: 21913905
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy for melanoma: the resultant of conflicting vectors.
    Mitchell MS
    J Clin Oncol; 2004 Jun; 22(11):2043-5. PubMed ID: 15123732
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease.
    Kharfan Dabaja MA; Morgensztern D; Markoe AM; Bartlett-Pandite L
    Am J Clin Oncol; 2000 Oct; 23(5):531-3. PubMed ID: 11039518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen-induced radiation recall dermatitis.
    Bourgeois A; Grisoli SB; Soine EJ; Rosen LB
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of palmar-plantar erythrodysesthesia possibly due to temozolomide with dexamethasone.
    Kanat O; Baskan BE; Kurt E; Evrensel T
    J Postgrad Med; 2007; 53(2):146. PubMed ID: 17495388
    [No Abstract]   [Full Text] [Related]  

  • 19. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
    Lev DC; Onn A; Melinkova VO; Miller C; Stone V; Ruiz M; McGary EC; Ananthaswamy HN; Price JE; Bar-Eli M
    J Clin Oncol; 2004 Jun; 22(11):2092-100. PubMed ID: 15123733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent radiation recall dermatitis triggered by radiological procedures in a patient with breast cancer.
    Emre S; Demirseren DD; Unal E; Sungu N
    Australas J Dermatol; 2019 Nov; 60(4):308-310. PubMed ID: 31012084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.